Skip to content
Screener

Guardant Health GH Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$19.17M
Myriad Genetics logo
Myriad GeneticsMYGN
NeoGenomics logo
NeoGenomicsNEO
Illumina logo
IlluminaILMN
Veracyte logo
VeracyteVCYT
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$22.61B+231%
Enterprise value$23.21B+212%
P/S20.9×+12.7×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Guardant Health’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 5:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001576280-26-000026
Line itemGross Carrying AmountAccumulated AmortizationNet Carrying AmountRemaining Weighted-Average Useful Life
Intangible assets subject to amortization:
Acquired license$11,886$(7,174)$4,7124.6
Non-compete agreements and other covenant rights5,100(5,100)0.0
Total intangible assets subject to amortization$16,986$(12,274)$4,712
Intangible assets not subject to amortization:
IPR&D$20,831$20,831
Goodwill77,25777,257
Total intangible assets not subject to amortization$98,088$98,088

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Guardant Health's finite-lived intangible assets, accumulated amortization?
Guardant Health (GH) reported finite-lived intangible assets, accumulated amortization of $12.27M in Q1 2026.
How has Guardant Health's finite-lived intangible assets, accumulated amortization changed year-over-year?
Guardant Health's finite-lived intangible assets, accumulated amortization increased by 14.6% year-over-year, from $10.71M to $12.27M.
What is the long-term trend for Guardant Health's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Guardant Health's finite-lived intangible assets, accumulated amortization has grown at a 37.4% compound annual growth rate (CAGR), from $2.43M to $11.9M.

Ask your AI about Guardant Health's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude